THE NANOGLUE SOLUTION

Cutting-edge nanotechnology to boost wound healing and keep skin transplants alive – made in Switzerland

Our unique formulation based on cutting-edge nanotechnology boosts the body's own capacity of self-healing and keeps bacterial infections in check. Our nanoparticle paste helps surgeons who want to ensure patient safety and survival by reducing skin transplantation complications and providing swift healing.

OUR MISSION

Every year, millions of patients worldwide receive skin transplants because of severe burns, sports injuries or diabetic wounds. One out of ten of these transplantations fails, often with dreadful complications. An aging society, the rise of diabetes and untreatable superbugs are bound to increase this failure rate. The last decades have brought little improvement in the field – most products focus on structure restoration or contain hugely expensive biologics.

We believe it's time for a change.

After decades of research, nanotechnology is mature enough to step into the breach and disrupt the wound care market.

OUR TECHNOLOGY

TISSUE BONDING

The so-called nano-bridging effect enables our nanoparticles to strongly connect different tissues. They ensure that transplants stay in place.

ABOUT US

We are an interdisciplinary team with backgrounds in nanoscience, process engineering and business administration. Nanoglue is developed in close collaboration with surgeons and leading medical experts. We believe it is time to streamline skin transplantations with an effective easy-to-apply solution that fits all cases.

TINO MATTER

CEO

PhD candidate in Nanomedicine at ETH Zurich and Empa St Gallen

Get in touch

SEBASTIAN LOY

CFO

MA Accounting & Finance at HSG

Get in touch

COLLABORATORS AND ADVISORS

Nanoglue collaborates with top-notch scientific and clinical institutions, such as ETH Zurich, Empa St. Gallen, UCL, the University Hospital Bern, the University Hospital Zurich and the University Hospital Birmingham.

2SWISSMEDIC-PORTRAETS-17-5779 Kopie copy_edited_edited.jpg

JÜRG H. SCHNETZER

Former Executive Director Swissmedic
Regulatory advisor

PROF. DR. INGE KATRIN HERRMANN

ETH Zurich | Empa St. Gallen
Scientific advisor

DR. ANDREA SCHLEGEL

University Hospital Birmingham
Clinical advisor

SUPPORT

GET IN TOUCH WITH US